Successful treatment of severe pyoderma gangrenosum with pimecrolimus cream 1%.
Bellini
V
V
Simonetti
S
S
Lisi
P
P
D000287:Administration, Topical; D000368:Aged; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D009824:Ointments; D017511:Pyoderma Gangrenosum / Q000188:drug therapy* / Q000473:pathology; D016559:Tacrolimus / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D009824:Ointments; C117268:pimecrolimus; D016559:Tacrolimus